Reports

Industry Research Reports

Home > Reports > Chemical & Material > Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Research Report 2024

Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Research Report 2024

Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Research Report 2024

Industry: Chemical & Material

Published Date: 2025-01-04

Pages: 126 Pages

Report ld: 3520986

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global market for Cytotoxic Active Pharmaceutical Ingredients (API) was valued at US$ 43170 million in the year 2023 and is projected to reach a revised size of US$ 87000 million by 2030, growing at a CAGR of 11.3% during the forecast period.

Cytotoxic API (Active Pharmaceutical Ingredient) refers to those pharmaceutical ingredients that have a toxic effect on cells. These ingredients are used in drug development for specific therapeutic purposes, such as killing or inhibiting the growth of certain cells, but can also have side effects on normal cells. Cytotoxicity apis are commonly used in cancer chemotherapy, immunotherapy, and other therapeutic areas that require inhibiting or killing specific cell types.

North American market for Cytotoxic Active Pharmaceutical Ingredients (API) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cytotoxic Active Pharmaceutical Ingredients (API) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Cytotoxic Active Pharmaceutical Ingredients (API) include Lonza, Merck KGaA, Catalent, Inc, Aenova, Hetero, Cambrex Corporation, Syngene, Pfizer CentreOne, Orion Corporation (Fermion Oy), Dishman Carbogen Amcis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

MARKET SEGMENTATION

By Company

  • Lonza
  • Merck KGaA
  • Catalent, Inc
  • Aenova
  • Hetero
  • Cambrex Corporation
  • Syngene
  • Pfizer CentreOne
  • Orion Corporation (Fermion Oy)
  • Dishman Carbogen Amcis
  • Aspen API
  • Aarti Pharmalabs
  • Abzena
  • Wavelength Pharmaceuticals
  • Eurofins CDMO
  • ChemCon GmbH
  • Aurigene
  • Scinopharm
  • IDT Australia
  • Olon
  • CritiTech
  • Fareva
  • Minafin (Minakem)
  • Pensatech Pharma
  • Natco Pharma Limited
  • Symbiosis Pharma
  • Axplora
  • Cerbios-Pharma SA
  • Tepnel Pharma Services

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Up To OEB 5
  • Up To OEB 4

Segment by Application

  • Tumors
  • Cancer
  • Other

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Cytotoxic Active Pharmaceutical Ingredients (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytotoxic Active Pharmaceutical Ingredients (API).

The Cytotoxic Active Pharmaceutical Ingredients (API) market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cytotoxic Active Pharmaceutical Ingredients (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cytotoxic Active Pharmaceutical Ingredients (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

marn_i1

Chapter 2: Detailed analysis of Cytotoxic Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Production/output, value of Cytotoxic Active Pharmaceutical Ingredients (API) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

marn_i1

Chapter 4: Consumption of Cytotoxic Active Pharmaceutical Ingredients (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

marn_i1

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 10: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Cytotoxic Active Pharmaceutical Ingredients (API) Market Overview

1.1 Product Definition

1.2 Cytotoxic Active Pharmaceutical Ingredients (API) by Type

1.2.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Value Growth Rate Analysis by Type: 2023 VS 2030

1.2.2 Up To OEB 5

1.2.3 Up To OEB 4

1.3 Cytotoxic Active Pharmaceutical Ingredients (API) by Application

1.3.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Value Growth Rate Analysis by Application: 2023 VS 2030

1.3.2 Tumors

1.3.3 Cancer

1.3.4 Other

1.4 Global Market Growth Prospects

1.4.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)

1.4.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Capacity Estimates and Forecasts (2019-2030)

1.4.3 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts (2019-2030)

1.4.4 Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Average Price Estimates and Forecasts (2019-2030)

1.5 Assumptions and Limitations

muLu

2 Market Competition by Manufacturers

2.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Manufacturers (2019-2024)

2.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share by Manufacturers (2019-2024)

2.3 Global Key Players of Cytotoxic Active Pharmaceutical Ingredients (API), Industry Ranking, 2022 VS 2023

2.4 Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Cytotoxic Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2019-2024)

2.6 Global Key Manufacturers of Cytotoxic Active Pharmaceutical Ingredients (API), Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Cytotoxic Active Pharmaceutical Ingredients (API), Product Offered and Application

2.8 Global Key Manufacturers of Cytotoxic Active Pharmaceutical Ingredients (API), Date of Enter into This Industry

2.9 Cytotoxic Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends

2.9.1 Cytotoxic Active Pharmaceutical Ingredients (API) Market Concentration Rate

2.9.2 Global 5 and 10 Largest Cytotoxic Active Pharmaceutical Ingredients (API) Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

muLu

3 Cytotoxic Active Pharmaceutical Ingredients (API) Production by Region

3.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value by Region (2019-2030)

3.2.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share by Region (2019-2024)

3.2.2 Global Forecasted Production Value of Cytotoxic Active Pharmaceutical Ingredients (API) by Region (2025-2030)

3.3 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.4 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production by Region (2019-2030)

3.4.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Region (2019-2024)

3.4.2 Global Forecasted Production of Cytotoxic Active Pharmaceutical Ingredients (API) by Region (2025-2030)

3.5 Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Price Analysis by Region (2019-2024)

3.6 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production and Value, Year-over-Year Growth

3.6.1 North America Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)

3.6.2 Europe Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)

3.6.3 China Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)

3.6.4 Japan Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)

muLu

4 Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Region

4.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

4.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2030)

4.2.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2030)

4.2.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Forecasted Consumption by Region (2025-2030)

4.3 North America

4.3.1 North America Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.3.2 North America Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.4.2 Europe Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.5.2 Asia Pacific Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2030)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.6.2 Latin America, Middle East & Africa Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

muLu

5 Segment by Type

5.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production by Type (2019-2030)

5.1.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production by Type (2019-2024)

5.1.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production by Type (2025-2030)

5.1.3 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Type (2019-2030)

5.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value by Type (2019-2030)

5.2.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value by Type (2019-2024)

5.2.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value by Type (2025-2030)

5.2.3 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share by Type (2019-2030)

5.3 Global Cytotoxic Active Pharmaceutical Ingredients (API) Price by Type (2019-2030)

muLu

6 Segment by Application

6.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production by Application (2019-2030)

6.1.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production by Application (2019-2024)

6.1.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production by Application (2025-2030)

6.1.3 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Application (2019-2030)

6.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value by Application (2019-2030)

6.2.1 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value by Application (2019-2024)

6.2.2 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value by Application (2025-2030)

6.2.3 Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share by Application (2019-2030)

6.3 Global Cytotoxic Active Pharmaceutical Ingredients (API) Price by Application (2019-2030)

muLu

7 Key Companies Profiled

7.1 Lonza

7.1.1 Lonza Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.1.2 Lonza Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.1.3 Lonza Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.1.4 Lonza Main Business and Markets Served

7.1.5 Lonza Recent Developments/Updates

7.2 Merck KGaA

7.2.1 Merck KGaA Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.2.2 Merck KGaA Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.2.3 Merck KGaA Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.2.4 Merck KGaA Main Business and Markets Served

7.2.5 Merck KGaA Recent Developments/Updates

7.3 Catalent, Inc

7.3.1 Catalent, Inc Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.3.2 Catalent, Inc Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.3.3 Catalent, Inc Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.3.4 Catalent, Inc Main Business and Markets Served

7.3.5 Catalent, Inc Recent Developments/Updates

7.4 Aenova

7.4.1 Aenova Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.4.2 Aenova Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.4.3 Aenova Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.4.4 Aenova Main Business and Markets Served

7.4.5 Aenova Recent Developments/Updates

7.5 Hetero

7.5.1 Hetero Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.5.2 Hetero Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.5.3 Hetero Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.5.4 Hetero Main Business and Markets Served

7.5.5 Hetero Recent Developments/Updates

7.6 Cambrex Corporation

7.6.1 Cambrex Corporation Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.6.2 Cambrex Corporation Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.6.3 Cambrex Corporation Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.6.4 Cambrex Corporation Main Business and Markets Served

7.6.5 Cambrex Corporation Recent Developments/Updates

7.7 Syngene

7.7.1 Syngene Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.7.2 Syngene Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.7.3 Syngene Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.7.4 Syngene Main Business and Markets Served

7.7.5 Syngene Recent Developments/Updates

7.8 Pfizer CentreOne

7.8.1 Pfizer CentreOne Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.8.2 Pfizer CentreOne Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.8.3 Pfizer CentreOne Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.8.4 Pfizer CentreOne Main Business and Markets Served

7.8.5 Pfizer CentreOne Recent Developments/Updates

7.9 Orion Corporation (Fermion Oy)

7.9.1 Orion Corporation (Fermion Oy) Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.9.2 Orion Corporation (Fermion Oy) Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.9.3 Orion Corporation (Fermion Oy) Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.9.4 Orion Corporation (Fermion Oy) Main Business and Markets Served

7.9.5 Orion Corporation (Fermion Oy) Recent Developments/Updates

7.10 Dishman Carbogen Amcis

7.10.1 Dishman Carbogen Amcis Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.10.2 Dishman Carbogen Amcis Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.10.3 Dishman Carbogen Amcis Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.10.4 Dishman Carbogen Amcis Main Business and Markets Served

7.10.5 Dishman Carbogen Amcis Recent Developments/Updates

7.11 Aspen API

7.11.1 Aspen API Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.11.2 Aspen API Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.11.3 Aspen API Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.11.4 Aspen API Main Business and Markets Served

7.11.5 Aspen API Recent Developments/Updates

7.12 Aarti Pharmalabs

7.12.1 Aarti Pharmalabs Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.12.2 Aarti Pharmalabs Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.12.3 Aarti Pharmalabs Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.12.4 Aarti Pharmalabs Main Business and Markets Served

7.12.5 Aarti Pharmalabs Recent Developments/Updates

7.13 Abzena

7.13.1 Abzena Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.13.2 Abzena Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.13.3 Abzena Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.13.4 Abzena Main Business and Markets Served

7.13.5 Abzena Recent Developments/Updates

7.14 Wavelength Pharmaceuticals

7.14.1 Wavelength Pharmaceuticals Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.14.2 Wavelength Pharmaceuticals Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.14.3 Wavelength Pharmaceuticals Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.14.4 Wavelength Pharmaceuticals Main Business and Markets Served

7.14.5 Wavelength Pharmaceuticals Recent Developments/Updates

7.15 Eurofins CDMO

7.15.1 Eurofins CDMO Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.15.2 Eurofins CDMO Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.15.3 Eurofins CDMO Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.15.4 Eurofins CDMO Main Business and Markets Served

7.15.5 Eurofins CDMO Recent Developments/Updates

7.16 ChemCon GmbH

7.16.1 ChemCon GmbH Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.16.2 ChemCon GmbH Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.16.3 ChemCon GmbH Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.16.4 ChemCon GmbH Main Business and Markets Served

7.16.5 ChemCon GmbH Recent Developments/Updates

7.17 Aurigene

7.17.1 Aurigene Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.17.2 Aurigene Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.17.3 Aurigene Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.17.4 Aurigene Main Business and Markets Served

7.17.5 Aurigene Recent Developments/Updates

7.18 Scinopharm

7.18.1 Scinopharm Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.18.2 Scinopharm Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.18.3 Scinopharm Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.18.4 Scinopharm Main Business and Markets Served

7.18.5 Scinopharm Recent Developments/Updates

7.19 IDT Australia

7.19.1 IDT Australia Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.19.2 IDT Australia Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.19.3 IDT Australia Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.19.4 IDT Australia Main Business and Markets Served

7.19.5 IDT Australia Recent Developments/Updates

7.20 Olon

7.20.1 Olon Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.20.2 Olon Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.20.3 Olon Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.20.4 Olon Main Business and Markets Served

7.20.5 Olon Recent Developments/Updates

7.21 CritiTech

7.21.1 CritiTech Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.21.2 CritiTech Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.21.3 CritiTech Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.21.4 CritiTech Main Business and Markets Served

7.21.5 CritiTech Recent Developments/Updates

7.22 Fareva

7.22.1 Fareva Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.22.2 Fareva Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.22.3 Fareva Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.22.4 Fareva Main Business and Markets Served

7.22.5 Fareva Recent Developments/Updates

7.23 Minafin (Minakem)

7.23.1 Minafin (Minakem) Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.23.2 Minafin (Minakem) Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.23.3 Minafin (Minakem) Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.23.4 Minafin (Minakem) Main Business and Markets Served

7.23.5 Minafin (Minakem) Recent Developments/Updates

7.24 Pensatech Pharma

7.24.1 Pensatech Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.24.2 Pensatech Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.24.3 Pensatech Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.24.4 Pensatech Pharma Main Business and Markets Served

7.24.5 Pensatech Pharma Recent Developments/Updates

7.25 Natco Pharma Limited

7.25.1 Natco Pharma Limited Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.25.2 Natco Pharma Limited Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.25.3 Natco Pharma Limited Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.25.4 Natco Pharma Limited Main Business and Markets Served

7.25.5 Natco Pharma Limited Recent Developments/Updates

7.26 Symbiosis Pharma

7.26.1 Symbiosis Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.26.2 Symbiosis Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.26.3 Symbiosis Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.26.4 Symbiosis Pharma Main Business and Markets Served

7.26.5 Symbiosis Pharma Recent Developments/Updates

7.27 Axplora

7.27.1 Axplora Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.27.2 Axplora Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.27.3 Axplora Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.27.4 Axplora Main Business and Markets Served

7.27.5 Axplora Recent Developments/Updates

7.28 Cerbios-Pharma SA

7.28.1 Cerbios-Pharma SA Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.28.2 Cerbios-Pharma SA Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.28.3 Cerbios-Pharma SA Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.28.4 Cerbios-Pharma SA Main Business and Markets Served

7.28.5 Cerbios-Pharma SA Recent Developments/Updates

7.29 Tepnel Pharma Services

7.29.1 Tepnel Pharma Services Cytotoxic Active Pharmaceutical Ingredients (API) Company Information

7.29.2 Tepnel Pharma Services Cytotoxic Active Pharmaceutical Ingredients (API) Product Portfolio

7.29.3 Tepnel Pharma Services Cytotoxic Active Pharmaceutical Ingredients (API) Production, Value, Price and Gross Margin (2019-2024)

7.29.4 Tepnel Pharma Services Main Business and Markets Served

7.29.5 Tepnel Pharma Services Recent Developments/Updates

muLu

8 Industry Chain and Sales Channels Analysis

8.1 Cytotoxic Active Pharmaceutical Ingredients (API) Industry Chain Analysis

8.2 Cytotoxic Active Pharmaceutical Ingredients (API) Key Raw Materials

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Cytotoxic Active Pharmaceutical Ingredients (API) Production Mode & Process

8.4 Cytotoxic Active Pharmaceutical Ingredients (API) Sales and Marketing

8.4.1 Cytotoxic Active Pharmaceutical Ingredients (API) Sales Channels

8.4.2 Cytotoxic Active Pharmaceutical Ingredients (API) Distributors

8.5 Cytotoxic Active Pharmaceutical Ingredients (API) Customers

muLu

9 Cytotoxic Active Pharmaceutical Ingredients (API) Market Dynamics

9.1 Cytotoxic Active Pharmaceutical Ingredients (API) Industry Trends

9.2 Cytotoxic Active Pharmaceutical Ingredients (API) Market Drivers

9.3 Cytotoxic Active Pharmaceutical Ingredients (API) Market Challenges

9.4 Cytotoxic Active Pharmaceutical Ingredients (API) Market Restraints

muLu

10 Research Findings and Conclusion

muLu

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Capacity (Ton) by Manufacturers in 2023
Table 4. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production by Manufacturers (2019-2024) & (Ton)
Table 5. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Manufacturers (2019-2024)
Table 6. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Share by Manufacturers (2019-2024)
Table 8. Global Key Players of Cytotoxic Active Pharmaceutical Ingredients (API), Industry Ranking, 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Cytotoxic Active Pharmaceutical Ingredients (API) as of 2023)
Table 10. Global Market Cytotoxic Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (US$/Kg) & (2019-2024)
Table 11. Global Key Manufacturers of Cytotoxic Active Pharmaceutical Ingredients (API), Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Cytotoxic Active Pharmaceutical Ingredients (API), Product Offered and Application
Table 13. Global Key Manufacturers of Cytotoxic Active Pharmaceutical Ingredients (API), Date of Enter into This Industry
Table 14. Global Cytotoxic Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) by Region (2019-2024)
Table 18. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share by Region (2019-2024)
Table 19. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) Forecast by Region (2025-2030)
Table 20. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share Forecast by Region (2025-2030)
Table 21. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Table 22. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton) by Region (2019-2024)
Table 23. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Region (2019-2024)
Table 24. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton) Forecast by Region (2025-2030)
Table 25. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share Forecast by Region (2025-2030)
Table 26. Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Average Price (US$/Kg) by Region (2019-2024)
Table 27. Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Average Price (US$/Kg) by Region (2025-2030)
Table 28. Global Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 29. Global Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2024) & (Ton)
Table 30. Global Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Market Share by Region (2019-2024)
Table 31. Global Cytotoxic Active Pharmaceutical Ingredients (API) Forecasted Consumption by Region (2025-2030) & (Ton)
Table 32. Global Cytotoxic Active Pharmaceutical Ingredients (API) Forecasted Consumption Market Share by Region (2019-2024)
Table 33. North America Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 34. North America Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2024) & (Ton)
Table 35. North America Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Country (2025-2030) & (Ton)
Table 36. Europe Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 37. Europe Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2024) & (Ton)
Table 38. Europe Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Country (2025-2030) & (Ton)
Table 39. Asia Pacific Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 40. Asia Pacific Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2024) & (Ton)
Table 41. Asia Pacific Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Region (2025-2030) & (Ton)
Table 42. Latin America, Middle East & Africa Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 43. Latin America, Middle East & Africa Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2024) & (Ton)
Table 44. Latin America, Middle East & Africa Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Country (2025-2030) & (Ton)
Table 45. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton) by Type (2019-2024)
Table 46. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton) by Type (2025-2030)
Table 47. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Type (2019-2024)
Table 48. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Type (2025-2030)
Table 49. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) by Type (2019-2024)
Table 50. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) by Type (2025-2030)
Table 51. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share by Type (2019-2024)
Table 52. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share by Type (2025-2030)
Table 53. Global Cytotoxic Active Pharmaceutical Ingredients (API) Price (US$/Kg) by Type (2019-2024)
Table 54. Global Cytotoxic Active Pharmaceutical Ingredients (API) Price (US$/Kg) by Type (2025-2030)
Table 55. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton) by Application (2019-2024)
Table 56. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton) by Application (2025-2030)
Table 57. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Application (2019-2024)
Table 58. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Application (2025-2030)
Table 59. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) by Application (2019-2024)
Table 60. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) by Application (2025-2030)
Table 61. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share by Application (2019-2024)
Table 62. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share by Application (2025-2030)
Table 63. Global Cytotoxic Active Pharmaceutical Ingredients (API) Price (US$/Kg) by Application (2019-2024)
Table 64. Global Cytotoxic Active Pharmaceutical Ingredients (API) Price (US$/Kg) by Application (2025-2030)
Table 65. Lonza Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 66. Lonza Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 67. Lonza Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 68. Lonza Main Business and Markets Served
Table 69. Lonza Recent Developments/Updates
Table 70. Merck KGaA Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 71. Merck KGaA Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 72. Merck KGaA Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Merck KGaA Main Business and Markets Served
Table 74. Merck KGaA Recent Developments/Updates
Table 75. Catalent, Inc Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 76. Catalent, Inc Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 77. Catalent, Inc Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Catalent, Inc Main Business and Markets Served
Table 79. Catalent, Inc Recent Developments/Updates
Table 80. Aenova Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 81. Aenova Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 82. Aenova Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Aenova Main Business and Markets Served
Table 84. Aenova Recent Developments/Updates
Table 85. Hetero Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 86. Hetero Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 87. Hetero Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Hetero Main Business and Markets Served
Table 89. Hetero Recent Developments/Updates
Table 90. Cambrex Corporation Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 91. Cambrex Corporation Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 92. Cambrex Corporation Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Cambrex Corporation Main Business and Markets Served
Table 94. Cambrex Corporation Recent Developments/Updates
Table 95. Syngene Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 96. Syngene Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 97. Syngene Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Syngene Main Business and Markets Served
Table 99. Syngene Recent Developments/Updates
Table 100. Pfizer CentreOne Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 101. Pfizer CentreOne Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 102. Pfizer CentreOne Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Pfizer CentreOne Main Business and Markets Served
Table 104. Pfizer CentreOne Recent Developments/Updates
Table 105. Orion Corporation (Fermion Oy) Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 106. Orion Corporation (Fermion Oy) Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 107. Orion Corporation (Fermion Oy) Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Orion Corporation (Fermion Oy) Main Business and Markets Served
Table 109. Orion Corporation (Fermion Oy) Recent Developments/Updates
Table 110. Dishman Carbogen Amcis Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 111. Dishman Carbogen Amcis Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 112. Dishman Carbogen Amcis Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Dishman Carbogen Amcis Main Business and Markets Served
Table 114. Dishman Carbogen Amcis Recent Developments/Updates
Table 115. Aspen API Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 116. Aspen API Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 117. Aspen API Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Aspen API Main Business and Markets Served
Table 119. Aspen API Recent Developments/Updates
Table 120. Aarti Pharmalabs Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 121. Aarti Pharmalabs Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 122. Aarti Pharmalabs Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Aarti Pharmalabs Main Business and Markets Served
Table 124. Aarti Pharmalabs Recent Developments/Updates
Table 125. Abzena Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 126. Abzena Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 127. Abzena Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. Abzena Main Business and Markets Served
Table 129. Abzena Recent Developments/Updates
Table 130. Wavelength Pharmaceuticals Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 131. Wavelength Pharmaceuticals Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 132. Wavelength Pharmaceuticals Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Wavelength Pharmaceuticals Main Business and Markets Served
Table 134. Wavelength Pharmaceuticals Recent Developments/Updates
Table 135. Eurofins CDMO Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 136. Eurofins CDMO Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 137. Eurofins CDMO Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 138. Eurofins CDMO Main Business and Markets Served
Table 139. Eurofins CDMO Recent Developments/Updates
Table 140. ChemCon GmbH Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 141. ChemCon GmbH Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 142. ChemCon GmbH Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 143. ChemCon GmbH Main Business and Markets Served
Table 144. ChemCon GmbH Recent Developments/Updates
Table 145. Aurigene Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 146. Aurigene Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 147. Aurigene Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 148. Aurigene Main Business and Markets Served
Table 149. Aurigene Recent Developments/Updates
Table 150. Scinopharm Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 151. Scinopharm Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 152. Scinopharm Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 153. Scinopharm Main Business and Markets Served
Table 154. Scinopharm Recent Developments/Updates
Table 155. IDT Australia Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 156. IDT Australia Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 157. IDT Australia Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 158. IDT Australia Main Business and Markets Served
Table 159. IDT Australia Recent Developments/Updates
Table 160. Olon Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 161. Olon Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 162. Olon Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 163. Olon Main Business and Markets Served
Table 164. Olon Recent Developments/Updates
Table 165. CritiTech Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 166. CritiTech Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 167. CritiTech Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 168. CritiTech Main Business and Markets Served
Table 169. CritiTech Recent Developments/Updates
Table 170. Fareva Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 171. Fareva Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 172. Fareva Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 173. Fareva Main Business and Markets Served
Table 174. Fareva Recent Developments/Updates
Table 175. Minafin (Minakem) Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 176. Minafin (Minakem) Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 177. Minafin (Minakem) Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 178. Minafin (Minakem) Main Business and Markets Served
Table 179. Minafin (Minakem) Recent Developments/Updates
Table 180. Pensatech Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 181. Pensatech Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 182. Pensatech Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 183. Pensatech Pharma Main Business and Markets Served
Table 184. Pensatech Pharma Recent Developments/Updates
Table 185. Natco Pharma Limited Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 186. Natco Pharma Limited Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 187. Natco Pharma Limited Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 188. Natco Pharma Limited Main Business and Markets Served
Table 189. Natco Pharma Limited Recent Developments/Updates
Table 190. Symbiosis Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 191. Symbiosis Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 192. Symbiosis Pharma Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 193. Symbiosis Pharma Main Business and Markets Served
Table 194. Symbiosis Pharma Recent Developments/Updates
Table 195. Axplora Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 196. Axplora Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 197. Axplora Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 198. Axplora Main Business and Markets Served
Table 199. Axplora Recent Developments/Updates
Table 200. Cerbios-Pharma SA Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 201. Cerbios-Pharma SA Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 202. Cerbios-Pharma SA Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 203. Cerbios-Pharma SA Main Business and Markets Served
Table 204. Cerbios-Pharma SA Recent Developments/Updates
Table 205. Tepnel Pharma Services Cytotoxic Active Pharmaceutical Ingredients (API) Company Information
Table 206. Tepnel Pharma Services Cytotoxic Active Pharmaceutical Ingredients (API) Specification and Application
Table 207. Tepnel Pharma Services Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 208. Tepnel Pharma Services Main Business and Markets Served
Table 209. Tepnel Pharma Services Recent Developments/Updates
Table 210. Key Raw Materials Lists
Table 211. Raw Materials Key Suppliers Lists
Table 212. Cytotoxic Active Pharmaceutical Ingredients (API) Distributors List
Table 213. Cytotoxic Active Pharmaceutical Ingredients (API) Customers List
Table 214. Cytotoxic Active Pharmaceutical Ingredients (API) Market Trends
Table 215. Cytotoxic Active Pharmaceutical Ingredients (API) Market Drivers
Table 216. Cytotoxic Active Pharmaceutical Ingredients (API) Market Challenges
Table 217. Cytotoxic Active Pharmaceutical Ingredients (API) Market Restraints
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources
Table 221. Authors List of This Report
muLu

List of Figures

Figure 1. Product Picture of Cytotoxic Active Pharmaceutical Ingredients (API)
Figure 2. Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Share by Type: 2023 VS 2030
Figure 4. Up To OEB 5 Product Picture
Figure 5. Up To OEB 4 Product Picture
Figure 6. Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Share by Application: 2023 VS 2030
Figure 8. Tumors
Figure 9. Cancer
Figure 10. Other
Figure 11. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) & (2019-2030)
Figure 13. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Capacity (Ton) & (2019-2030)
Figure 14. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production (Ton) & (2019-2030)
Figure 15. Global Cytotoxic Active Pharmaceutical Ingredients (API) Average Price (US$/Kg) & (2019-2030)
Figure 16. Cytotoxic Active Pharmaceutical Ingredients (API) Report Years Considered
Figure 17. Cytotoxic Active Pharmaceutical Ingredients (API) Production Share by Manufacturers in 2023
Figure 18. Cytotoxic Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. The Global 5 and 10 Largest Players: Market Share by Cytotoxic Active Pharmaceutical Ingredients (API) Revenue in 2023
Figure 20. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 22. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 23. Global Cytotoxic Active Pharmaceutical Ingredients (API) Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 24. North America Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. Europe Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. China Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Japan Cytotoxic Active Pharmaceutical Ingredients (API) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Global Cytotoxic Active Pharmaceutical Ingredients (API) Consumption by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 29. Global Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 31. North America Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Market Share by Country (2019-2030)
Figure 32. U.S. Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 33. Canada Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 34. Europe Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 35. Europe Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Market Share by Country (2019-2030)
Figure 36. Germany Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 37. France Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 38. U.K. Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 39. Italy Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 40. Russia Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 41. Asia Pacific Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 42. Asia Pacific Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Market Share by Region (2025-2030)
Figure 43. China Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 44. Japan Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 45. South Korea Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 46. China Taiwan Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 47. Southeast Asia Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 48. India Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 49. Latin America, Middle East & Africa Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 50. Latin America, Middle East & Africa Cytotoxic Active Pharmaceutical Ingredients (API) Consumption Market Share by Country (2019-2030)
Figure 51. Mexico Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 52. Brazil Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 53. Turkey Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 54. GCC Countries Cytotoxic Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2019-2030) & (Ton)
Figure 55. Global Production Market Share of Cytotoxic Active Pharmaceutical Ingredients (API) by Type (2019-2030)
Figure 56. Global Production Value Market Share of Cytotoxic Active Pharmaceutical Ingredients (API) by Type (2019-2030)
Figure 57. Global Cytotoxic Active Pharmaceutical Ingredients (API) Price (US$/Kg) by Type (2019-2030)
Figure 58. Global Production Market Share of Cytotoxic Active Pharmaceutical Ingredients (API) by Application (2019-2030)
Figure 59. Global Production Value Market Share of Cytotoxic Active Pharmaceutical Ingredients (API) by Application (2019-2030)
Figure 60. Global Cytotoxic Active Pharmaceutical Ingredients (API) Price (US$/Kg) by Application (2019-2030)
Figure 61. Cytotoxic Active Pharmaceutical Ingredients (API) Value Chain
Figure 62. Cytotoxic Active Pharmaceutical Ingredients (API) Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Cytotoxic Active Pharmaceutical Ingredients (API) in 2025?zhanKai
The global market size of Cytotoxic Active Pharmaceutical Ingredients (API) in 2025 was 43170 Million USD.
What is the annual compound growth rate of the global Cytotoxic Active Pharmaceutical Ingredients (API) market size from 2025 to 2031?shouQi
Which companies rank high in the global Cytotoxic Active Pharmaceutical Ingredients (API) market?shouQi
Which region is expected to have the highest market share?shouQi
den_biaoTiZhungShi

Related Reports

Global Cytotoxic Active Pharmaceutical Ingredients (API) Market Research Report 2024

Industry: Chemical & Material

Published Date: 2025-01-04

Pages: 126 Pages

Report ld: 3520986

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Offline

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Offline

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Online

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Online

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

REPORT SCOPE

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now